BE1002427A3 - Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament. - Google Patents

Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament. Download PDF

Info

Publication number
BE1002427A3
BE1002427A3 BE8800177A BE8800177A BE1002427A3 BE 1002427 A3 BE1002427 A3 BE 1002427A3 BE 8800177 A BE8800177 A BE 8800177A BE 8800177 A BE8800177 A BE 8800177A BE 1002427 A3 BE1002427 A3 BE 1002427A3
Authority
BE
Belgium
Prior art keywords
medicine
novel
preparation
piperazinecarboxylic acid
piperazinecarboxylic
Prior art date
Application number
BE8800177A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002427A3 publication Critical patent/BE1002427A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE8800177A 1987-02-18 1988-02-12 Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament. BE1002427A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (1)

Publication Number Publication Date
BE1002427A3 true BE1002427A3 (fr) 1991-02-05

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800177A BE1002427A3 (fr) 1987-02-18 1988-02-12 Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament.

Country Status (28)

Country Link
JP (1) JPH0723387B2 (fi)
KR (1) KR960015190B1 (fi)
AT (1) AT391320B (fi)
AU (1) AU613009B2 (fi)
BE (1) BE1002427A3 (fi)
CA (1) CA1327799C (fi)
CH (1) CH675125A5 (fi)
CY (1) CY1739A (fi)
DE (1) DE3804936C2 (fi)
DK (1) DK168441B1 (fi)
ES (2) ES2011319A6 (fi)
FI (1) FI86733C (fi)
FR (1) FR2610932B1 (fi)
GB (2) GB8703749D0 (fi)
GR (1) GR1002471B (fi)
HK (1) HK142093A (fi)
HU (2) HU199858B (fi)
IE (1) IE59098B1 (fi)
IL (1) IL85436A0 (fi)
IT (1) IT1219447B (fi)
LU (1) LU87129A1 (fi)
MY (1) MY103206A (fi)
NL (1) NL8800412A (fi)
NZ (1) NZ223529A (fi)
PH (1) PH25512A (fi)
PT (1) PT86776B (fi)
SE (1) SE467256B (fi)
ZA (1) ZA881146B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
US6214604B1 (en) * 1995-05-08 2001-04-10 Lonza Ag Biotechnical production process of piperazine R-α-carboxylic acids and piperazine S-α-carboxylic acid amide
EA001904B1 (ru) 1997-05-12 2001-10-22 ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. Арилзамещенные пиперазины для лечения доброкачественной гиперплазии простаты
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159889A2 (en) * 1984-04-17 1985-10-30 Btg International Limited 4-Substituted piperazine-2-carboxylic acids process and pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159889A2 (en) * 1984-04-17 1985-10-30 Btg International Limited 4-Substituted piperazine-2-carboxylic acids process and pharmaceutical compositions

Also Published As

Publication number Publication date
JPH0723387B2 (ja) 1995-03-15
FI86733B (fi) 1992-06-30
ATA36788A (de) 1990-03-15
GR1002471B (el) 1996-11-15
SE8800541A (fi) 1988-08-19
NL8800412A (nl) 1988-09-16
AU1175888A (en) 1988-08-25
DK79688A (da) 1988-08-19
IT8847631A0 (it) 1988-02-12
IE880413L (en) 1988-08-18
HK142093A (en) 1994-01-07
HUT49361A (en) 1989-09-28
HU199858B (en) 1990-03-28
NZ223529A (en) 1991-02-26
DK79688D0 (da) 1988-02-16
GR880100084A (el) 1988-12-16
FR2610932B1 (fr) 1990-11-16
IT1219447B (it) 1990-05-18
ES2021904A6 (es) 1991-11-16
AT391320B (de) 1990-09-25
PH25512A (en) 1991-07-24
SE467256B (sv) 1992-06-22
MY103206A (en) 1993-05-29
FI880744A (fi) 1988-08-19
ZA881146B (en) 1989-10-25
GB2201676B (en) 1991-01-02
IL85436A (fi) 1992-12-01
PT86776B (pt) 1992-05-29
KR960015190B1 (ko) 1996-11-01
GB8803438D0 (en) 1988-03-16
FI880744A0 (fi) 1988-02-17
DE3804936A1 (de) 1988-09-01
CY1739A (en) 1995-10-20
IL85436A0 (en) 1988-07-31
PT86776A (pt) 1988-03-01
DK168441B1 (da) 1994-03-28
JPS63203691A (ja) 1988-08-23
DE3804936C2 (de) 1997-02-13
ES2011319A6 (es) 1990-01-01
LU87129A1 (fr) 1988-09-20
FI86733C (fi) 1992-10-12
SE8800541D0 (sv) 1988-02-17
AU613009B2 (en) 1991-07-25
FR2610932A1 (fr) 1988-08-19
CA1327799C (en) 1994-03-15
HU211269A9 (en) 1995-11-28
IE59098B1 (en) 1994-01-12
GB8703749D0 (en) 1987-03-25
GB2201676A (en) 1988-09-07
CH675125A5 (fi) 1990-08-31
KR880009944A (ko) 1988-10-06

Similar Documents

Publication Publication Date Title
ES8609251A1 (es) Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida
TNSN97032A1 (fr) Nouvelles oxazolidinones substituees, procedes pour les preparer, et leur utilisation en tant que medicaments.
LU90710I2 (fr) Galanthamine ou ses sels d'addition acides
KR870700620A (ko) 신규 약리학적 화합물
BE1002427A3 (fr) Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
EP0330052A3 (de) Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
ATE26273T1 (de) 3-indolcarboxamid-verbindungen.
ES8404850A1 (es) Procedimiento para la obtencion de 2-nitro-1,1-etendiaminas
EP0328203A3 (en) [5(6) (1H-azole-1-ylmethyl)benzimidazole] carbamates
FR2450820A1 (fr) Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation
ES8705396A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
KR860000269A (ko) 칼슘길항성의 1-[비스-(4-플루오로페닐)-메틸-4-(3-페닐-2-프로페닐)-헥사하이드로-1h-1, 4-디아제핀의 제조방법및 이것을 함유한 약학적조성물
DK167384D0 (da) Penemer,farmaceutiske praeparater indeholdende disse,samt fremgangsmaader til fremstilling deraf
FR2368473A1 (fr) O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs
ATE90673T1 (de) Antifolat-mittel.
ATE26841T1 (de) Verbindungen zur behandlung von erhoehtem blutdruck.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
SE8701592D0 (sv) A pharmaceutical composition comprising an organic zinc complex and a process for preparing the active substance
FR2435465A1 (fr) Aminoalcoylguanidines substituees, leur preparation et leur application a titre de medicaments
FR2374321A1 (fr) Utilisation de quinoxalinedioxydes pour promouvoir la croissance et ameliorer le rendement alimentaire d'animaux
KR900011757A (ko) 피리디늄 니트레이트, 그의 제조방법 및 용도
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas